Literature DB >> 33584632

Animal Models of Phage Therapy.

Samuel Penziner1, Robert T Schooley1, David T Pride1,2.   

Abstract

Amidst the rising tide of antibiotic resistance, phage therapy holds promise as an alternative to antibiotics. Most well-designed studies on phage therapy exist in animal models. In order to progress to human clinical trials, it is important to understand what these models have accomplished and determine how to improve upon them. Here we provide a review of the animal models of phage therapy in Western literature and outline what can be learned from them in order to bring phage therapy closer to becoming a feasible alternative to antibiotics in clinical practice.
Copyright © 2021 Penziner, Schooley and Pride.

Entities:  

Keywords:  animal models; bacterial infections; bacteriophage; phage; phage therapy

Year:  2021        PMID: 33584632      PMCID: PMC7876411          DOI: 10.3389/fmicb.2021.631794

Source DB:  PubMed          Journal:  Front Microbiol        ISSN: 1664-302X            Impact factor:   5.640


  138 in total

1.  Therapeutic effectiveness of bacteriophages in the rescue of mice with extended spectrum beta-lactamase-producing Escherichia coli bacteremia.

Authors:  Jing Wang; Bei Hu; Minchao Xu; Qun Yan; Shuangyou Liu; Xuhui Zhu; Ziyong Sun; Deding Tao; Li Ding; Eddie Reed; Jianping Gong; Qingdi Q Li; Junbo Hu
Journal:  Int J Mol Med       Date:  2006-02       Impact factor: 4.101

2.  Experimental bacteriophage protection against Staphylococcus aureus abscesses in a rabbit model.

Authors:  Quintin F Wills; Claire Kerrigan; James S Soothill
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

3.  The actvity of mouse Kupffer cells following intravenous injection of T4 bacteriophage.

Authors:  C J Inchley
Journal:  Clin Exp Immunol       Date:  1969-07       Impact factor: 4.330

4.  A novel chimeric phage lysin with high in vitro and in vivo bactericidal activity against Streptococcus pneumoniae.

Authors:  Roberto Díez-Martínez; Héctor D De Paz; Esther García-Fernández; Noemí Bustamante; Chad W Euler; Vincent A Fischetti; Margarita Menendez; Pedro García
Journal:  J Antimicrob Chemother       Date:  2015-03-01       Impact factor: 5.790

5.  Antipseudomonal Bacteriophage Reduces Infective Burden and Inflammatory Response in Murine Lung.

Authors:  Rishi Pabary; Charanjit Singh; Sandra Morales; Andrew Bush; Khalid Alshafi; Diana Bilton; Eric W F W Alton; Anthony Smithyman; Jane C Davies
Journal:  Antimicrob Agents Chemother       Date:  2015-11-16       Impact factor: 5.191

6.  Treatment of experimental infections of mice with bacteriophages.

Authors:  J S Soothill
Journal:  J Med Microbiol       Date:  1992-10       Impact factor: 2.472

7.  The control of experimental Escherichia coli diarrhoea in calves by means of bacteriophages.

Authors:  H W Smith; M B Huggins; K M Shaw
Journal:  J Gen Microbiol       Date:  1987-05

8.  Experimental phage therapy against Staphylococcus aureus in mice.

Authors:  Rosanna Capparelli; Marianna Parlato; Giorgia Borriello; Paola Salvatore; Domenico Iannelli
Journal:  Antimicrob Agents Chemother       Date:  2007-05-21       Impact factor: 5.191

9.  Co-therapy using lytic bacteriophage and linezolid: effective treatment in eliminating methicillin resistant Staphylococcus aureus (MRSA) from diabetic foot infections.

Authors:  Sanjay Chhibber; Tarsem Kaur
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

10.  Phage therapy is effective against infection by Mycobacterium ulcerans in a murine footpad model.

Authors:  Gabriela Trigo; Teresa G Martins; Alexandra G Fraga; Adhemar Longatto-Filho; António G Castro; Joana Azeredo; Jorge Pedrosa
Journal:  PLoS Negl Trop Dis       Date:  2013-04-25
View more
  4 in total

Review 1.  Bacteriophage Therapy for Staphylococcus Aureus Infections: A Review of Animal Models, Treatments, and Clinical Trials.

Authors:  Lucile Plumet; Nour Ahmad-Mansour; Catherine Dunyach-Remy; Karima Kissa; Albert Sotto; Jean-Philippe Lavigne; Denis Costechareyre; Virginie Molle
Journal:  Front Cell Infect Microbiol       Date:  2022-06-17       Impact factor: 6.073

Review 2.  A Phage Foundry Framework to Systematically Develop Viral Countermeasures to Combat Antibiotic-Resistant Bacterial Pathogens.

Authors:  Vivek K Mutalik; Adam P Arkin
Journal:  iScience       Date:  2022-03-19

3.  Bacteriophage as a potential therapy to control antibiotic-resistant Pseudomonas aeruginosa infection through topical application onto a full-thickness wound in a rat model.

Authors:  Nouran Rezk; Abdallah S Abdelsattar; Doaa Elzoghby; Mona M Agwa; Mohamed Abdelmoteleb; Rania G Aly; Mohamed S Fayez; Kareem Essam; Bishoy M Zaki; Ayman El-Shibiny
Journal:  J Genet Eng Biotechnol       Date:  2022-09-12

4.  Modification of the immune response by bacteriophages alters methicillin-resistant Staphylococcus aureus infection.

Authors:  Tomoya Suda; Tomoko Hanawa; Mayuko Tanaka; Yasunori Tanji; Kazuhiko Miyanaga; Sanae Hasegawa-Ishii; Ken Shirato; Takako Kizaki; Takeaki Matsuda
Journal:  Sci Rep       Date:  2022-09-19       Impact factor: 4.996

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.